SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?


To: Heat Shock who wrote (61)10/23/1998 1:43:00 PM
From: Larry Meneely  Respond to of 236
 
Heat Shock: Thanks for the link. I followed up the link to Quintiles Transnational. They do "drug development and marketing" and "accelerate the development and availability of important medicines" with "integrated services to help our pharmaceutical and health care customers".
This is what I have come to appreciate about Stressgen: they are not only promising research scientists, but they seem genuinely interested in having a viable pharmaceutical business.
Quintiles Transnational are very successful and should be good for Stressgen: quintiles.com

Thanks again for the link - waiting developments patiently.
Larry M.



To: Heat Shock who wrote (61)10/26/1998 12:24:00 AM
From: james paterson  Read Replies (1) | Respond to of 236
 
Thanks for the repost. It's been along time since we've had any news regarding preclinical trials.

Share price seems to have found a base & I don't think it would take much in the way of news to send it at least $1.00 higher.